[Skin fibrosis : Novel insights in pathophysiology and treatment]

Sebastian Willenborg1, Sabrina Satzinger1, Sabine A Eming2,3,4,5

  • 1Klinik und Poliklinik für Dermatologie und Venerologie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.

PubMed

Insights

Understanding fibrosing diseases, like those affecting skin, is crucial as current treatments are limited. This research highlights the immune response

Area of Science:

  • Dermatology and Immunology
  • Molecular and Cellular Biology
  • Pathophysiology of Fibrosis

Context:

  • Fibrosing diseases affect multiple organ systems, leading to significant functional loss, reduced quality of life, and increased mortality.
  • Current therapeutic strategies for fibrotic conditions are limited, with a lack of understanding regarding tissue-specific and common pathogenic mechanisms.
  • The unmet medical need for effective treatments for fibrotic diseases necessitates novel, cause-based therapeutic approaches.

Purpose:

  • To review recent findings on the role of the immune response in fibrogenesis.
  • To elucidate the complex cellular and molecular mechanisms underlying fibrotic alterations.
  • To identify potential targets for novel therapeutic interventions in fibrotic diseases.

Summary:

  • This review focuses on the critical involvement of the immune system in the development of fibrosis.
  • It synthesizes recent research on the pathophysiology of fibrotic diseases across various organs.
  • Key findings regarding the immune response's contribution to fibrogenesis are presented.

Impact:

  • Provides a foundation for developing more effective, targeted therapies for fibrotic conditions.
  • Contributes to a deeper understanding of the immune system's role in disease pathogenesis.
  • Offers potential avenues for improving patient outcomes and reducing disease-related morbidity and mortality.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K